32035419|t|Riluzole: a therapeutic strategy in Alzheimer's disease by targeting the WNT/beta-catenin pathway.
32035419|a|Alzheimer's disease (AD) is a neurodegenerative disease, where the etiology remains unclear. AD is characterized by amyloid-(Abeta) protein aggregation and neurofibrillary plaques deposits. Oxidative stress and chronic inflammation have been suggested as causes of AD. Glutamatergic pathway dysregulation is also mainly associated with AD process. In AD, the canonical WNT/beta-catenin pathway is downregulated. Downregulation of WNT/beta-catenin, by activation of GSK-3beta-induced Abeta, and inactivation of PI3K/Akt pathway involve oxidative stress in AD. The downregulation of the WNT/beta-catenin pathway decreases the activity of EAAT2, the glutamate receptors, and leads to neuronal death. In AD, oxidative stress, neuroinflammation and glutamatergic pathway operate in a vicious circle driven by the dysregulation of the WNT/beta-catenin pathway. Riluzole is a glutamate modulator and used as treatment in amyotrophic lateral sclerosis. Recent findings have highlighted its use in AD and its potential increase power on the WNT pathway. Nevertheless, the mechanism by which Riluzole can operate in AD remains unclear and should be better determine. The focus of our review is to highlight the potential action of Riluzole in AD by targeting the canonical WNT/beta-catenin pathway to modulate glutamatergic pathway, oxidative stress and neuroinflammation.
32035419	0	8	Riluzole	Chemical	MESH:D019782
32035419	36	55	Alzheimer's disease	Disease	MESH:D000544
32035419	77	89	beta-catenin	Gene	1499
32035419	99	118	Alzheimer's disease	Disease	MESH:D000544
32035419	120	122	AD	Disease	MESH:D000544
32035419	129	154	neurodegenerative disease	Disease	MESH:D019636
32035419	192	194	AD	Disease	MESH:D000544
32035419	224	229	Abeta	Gene	351
32035419	255	278	neurofibrillary plaques	Disease	MESH:D003773
32035419	310	330	chronic inflammation	Disease	MESH:D007249
32035419	364	366	AD	Disease	MESH:D000544
32035419	435	437	AD	Disease	MESH:D000544
32035419	450	452	AD	Disease	MESH:D000544
32035419	472	484	beta-catenin	Gene	1499
32035419	533	545	beta-catenin	Gene	1499
32035419	564	573	GSK-3beta	Gene	2932
32035419	582	587	Abeta	Gene	351
32035419	614	617	Akt	Gene	207
32035419	654	656	AD	Disease	MESH:D000544
32035419	688	700	beta-catenin	Gene	1499
32035419	735	740	EAAT2	Gene	6506
32035419	780	794	neuronal death	Disease	MESH:D009410
32035419	799	801	AD	Disease	MESH:D000544
32035419	821	838	neuroinflammation	Disease	MESH:D000090862
32035419	932	944	beta-catenin	Gene	1499
32035419	954	962	Riluzole	Chemical	MESH:D019782
32035419	968	977	glutamate	Chemical	MESH:D018698
32035419	1013	1042	amyotrophic lateral sclerosis	Disease	MESH:D000690
32035419	1088	1090	AD	Disease	MESH:D000544
32035419	1181	1189	Riluzole	Chemical	MESH:D019782
32035419	1205	1207	AD	Disease	MESH:D000544
32035419	1320	1328	Riluzole	Chemical	MESH:D019782
32035419	1332	1334	AD	Disease	MESH:D000544
32035419	1366	1378	beta-catenin	Gene	1499
32035419	1443	1460	neuroinflammation	Disease	MESH:D000090862
32035419	Association	MESH:D000544	1499
32035419	Association	MESH:D000090862	1499
32035419	Association	MESH:D000544	2932
32035419	Negative_Correlation	1499	6506
32035419	Positive_Correlation	2932	351
32035419	Negative_Correlation	MESH:D019782	MESH:D000690
32035419	Association	MESH:D019782	MESH:D000090862
32035419	Negative_Correlation	MESH:D000544	207
32035419	Association	MESH:D018698	MESH:D019782
32035419	Association	MESH:D019782	1499
32035419	Association	MESH:D000544	351
32035419	Association	MESH:D009410	1499
32035419	Negative_Correlation	MESH:D019782	MESH:D000544

